The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCLA.L Regulatory News (GCLA)

  • There is currently no data for GCLA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

2 Aug 2017 07:00

RNS Number : 8090M
Grupo Clarin S.A.
02 August 2017
 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

 

(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

 

(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.

 

(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

 

(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

Please complete all relevant boxes should in block capital letters.

 

1. Name of the issuer

 

GRUPO CLARÍN S.A.

....................................

 

2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii):

 

....................................

 

3. Name of person discharging managerial responsibilities/director

 

ALEJANDRO ALBERTO URRICELQUI (MANAGER)

SEBASTIAN BARDENGO (MANAGER and ALTERNATE DIRECTOR)

 

....................................

 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

 

....................................

 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

 

3 ABOVE

....................................

 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

- URRICELQUI - CLASS B COMMON SHARES OF THE COMPANY, WITH NOMINAL VALUE OF ONE (1) ARGENTINE PESO PER SHARE IN THE FORM OF GLOBAL DEPOSITARY SHARES

 

 - BARDENGO - CLASS B COMMON SHARES OF THE COMPANY, WITH NOMINAL VALUE OF ONE (1) ARGENTINE PESO PER SHARE

 

....................................

 

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

N/A

....................................

 

8. State the nature of the transaction

 

- URRICELQUI - ACQUISITION OF CLASS B COMMON SHARES IN THE FORM OF GLOBAL DEPOSITARY SHARES

 

-BARDENGO - ACQUISITION OF CLASS B COMMON SHARES

 

 

9. Number of shares, debentures or financial instruments relating to shares acquired

 

 

ALEJANDRO A. URRICELQUI Number of shares: 31,000 GDSs, representing 2 Class B Common Shares each

 

SEBASTIAN BARDENGO Number of shares: 1,460 Class B Common Shares

....................................

 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

ALEJANDRO A. URRICELQUI Percentage: 0.0333% of CLASS B COMMON SHARES

 

 

SEBASTIAN BARDENGO Percentage: 0.0008% of CLASS B COMMON SHARES

....................................

 

11. Number of shares, debentures or financial instruments relating to shares disposed

N/A

....................................

 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

....................................

 

 

13. Price per share or value of transaction

 

 

ALEJANDRO A. URRICELQUI 31,000 GDS at US$ 28.38 per GDS

 

SEBASTIAN BARDENGO: 1,460 shares at AR$ 239.12 per share

 

 

14. Date and place of transaction

 

 

ALEJANDRO A. URRICELQUI: 31,000 GDS on 21, 24 and 26 July 2017, LONDON

 

SEBASTIAN BARDENGO: 1,460 SHARES on 20 July 2017, Buenos Aires

....................................

 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

ALEJANDRO A. URRICELQUI:

173,158 COMMON SHARES (0.0602% OF OUTSTANDING CAPITAL STOCK)

 

SEBASTIAN BARDENGO:

6,460 COMMON SHARES (0.0022% OF OUTSTANDING CAPITAL STOCK)

 

 

....................................

 

16. Date issuer informed of transaction

 

....................................

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17. Date of grant

....................................

18. Period during which or date on which it can be exercised

....................................

19. Total amount paid (if any) for grant of the option

....................................

20. Description of shares or debentures involved (class and number)

....................................

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

....................................

22. Total number of shares or debentures over which options held following notification

....................................

 

23. Any additional information

 

N/A

....................................

 

24. Name of contact and telephone number for queries

 

IN BUENOS AIRES:

AGUSTIN MEDINA MANSON/PATRICIO GENTILE

GRUPO CLARÍN

EMAIL: INVESTORS@GRUPOCLARIN.COM

 

IN LONDON:

ALEX MONEY

JASFORD IR

TEL: +44 20 3289 5300

EMAIL: ALEXM@JASFORD.COM 

 

IN NEW YORK:

MELANIE CARPENTER

I-ADVIZE CORPORATE COMMUNICATIONS

TEL: +1 212 406 3692

EMAIL: CLARIN@I-ADVIZE.COM

....................................

Name and signature of duly authorised officer of issuer responsible for making notification

 

AGUSTIN MEDINA MANSON, Responsible for Market Relations, Grupo Clarín S.A.

....................................

Date of notification

August 1st, 2017

....................................

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSSFMFFWSEFA
Date   Source Headline
13th Aug 20198:48 amRNSFirst Half and Second Quarter 2019 Results
6th Aug 20198:37 amRNSNotice of Results
24th May 20197:40 amRNSFirst Quarter 2019 Results (1Q19)
22nd May 20197:56 amRNSConference call and webcast for Q1 2019 results
8th May 20195:12 pmRNS[Replacement] Ordinary Shareholders' Meeting
8th May 20195:01 pmRNS[Replacement] Appointment of Company Authorities
8th May 20194:58 pmRNSAppointment of Company Authorities
3rd May 20198:34 amRNSGrupo Clarin Appoints Company Authorities
3rd May 20198:29 amRNSGCSA holds Annual Ordinary Shareholders' Meeting
29th Apr 20197:00 amRNSAnnual Financial Report
26th Apr 20198:05 amRNSDirectorate Change
17th Apr 20197:06 amRNSResponse to Shareholder Information Request
8th Apr 20192:40 pmRNSGrupo Clarín Publishes List of Errata
26th Mar 20195:05 pmRNSGrupo Clarín Calls Annual Shareholders' Meeting
12th Mar 20198:00 amRNSFourth Quarter and Full Year 2018 Results
14th Dec 20184:36 pmRNSPrice Monitoring Extension
23rd Nov 20185:47 pmRNSGrupo Clarin Assigns Credit to Cablevision Holding
9th Nov 20187:45 amRNSThird Quarter and Nine-Month 2018 Results
5th Nov 20187:00 amRNSConference call and webcast for Q3 2018 results
22nd Aug 20183:45 pmRNSSecond Price Monitoring Extn
22nd Aug 20183:40 pmRNSPrice Monitoring Extension
10th Aug 20187:00 amRNSFirst Half and Second Quarter 2018 Results
6th Aug 20187:00 amRNSNotice of Results
20th Jun 20187:00 amRNSGrupo Clarín Settles Claims
15th Jun 20183:45 pmRNSSecond Price Monitoring Extn
15th Jun 20183:40 pmRNSPrice Monitoring Extension
23rd May 20183:45 pmRNSSecond Price Monitoring Extn
23rd May 20183:40 pmRNSPrice Monitoring Extension
15th May 20183:45 pmRNSSecond Price Monitoring Extn
15th May 20183:40 pmRNSPrice Monitoring Extension
14th May 20183:40 pmRNSPrice Monitoring Extension
11th May 20187:00 amRNSGrupo Clarín Announces First Quarter 2018 Results
8th May 20187:00 amRNSConference call and webcast for Q1 2018 results
26th Apr 20187:00 amRNSAnnual Financial Report
23rd Apr 20187:46 amRNSAnnual Ordinary Shareholders' Meeting
10th Apr 20187:35 amRNSResponse to Information Request
22nd Mar 20187:00 amRNSGrupo Clarin Calls Annual Shareholders` Meeting
12th Mar 20187:00 amRNSFourth Quarter and Full Year 2017 Results
6th Mar 20189:51 amRNSNotice of Results
16th Feb 20187:00 amRNSDirector/PDMR Shareholding
3rd Jan 20188:31 amRNSDirectorate Change
29th Dec 20177:00 amRNSResignations of Alternate Board Members
15th Nov 201712:26 pmRNSDirectorate Change
10th Nov 20177:00 amRNS3rd Quarter and Nine-Month 2017 Results
3rd Nov 20177:00 amRNSCall and Presentation for Q3 2017 Results
29th Aug 20175:25 pmRNSDirector/PDMR Shareholding
23rd Aug 20177:00 amRNSAnnouncement of Split-Up Share Distribution Date
11th Aug 20171:01 pmRNSAppendix to 1H17 and 2Q17 Results
11th Aug 20171:00 pmRNSResults for First Half and Second Quarter of 2017
7th Aug 20177:02 amRNSCall and Presentation to discuss Q2 2017 results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.